Prevention and management of osteonecrosis of the jaw secondary to bone-targeted therapy in patients with kidney cancer. [electronic resource]
Producer: 20180105Description: 273-80 p. digitalISSN:- 1751-4266
- Bisphosphonate-Associated Osteonecrosis of the Jaw -- prevention & control
- Bone Density Conservation Agents -- administration & dosage
- Bone Neoplasms -- prevention & control
- Clinical Trials as Topic
- Denosumab -- administration & dosage
- Diphosphonates -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Female
- Humans
- Imidazoles -- administration & dosage
- Kidney Neoplasms -- pathology
- Male
- Quality of Life
- Sex Factors
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.